Simplicity Wealth LLC Takes $1.05 Million Position in The Clorox Company (NYSE:CLX)

Simplicity Wealth LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 7,118 shares of the company's stock, valued at approximately $1,048,000.

Several other large investors have also recently modified their holdings of the business. Norges Bank bought a new position in Clorox during the fourth quarter worth $259,041,000. FMR LLC raised its stake in Clorox by 75.4% during the fourth quarter. FMR LLC now owns 1,361,758 shares of the company's stock worth $221,163,000 after buying an additional 585,526 shares during the last quarter. Marshall Wace LLP raised its stake in Clorox by 549.8% during the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company's stock worth $88,144,000 after buying an additional 459,203 shares during the last quarter. ExodusPoint Capital Management LP raised its stake in Clorox by 187.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company's stock worth $113,508,000 after buying an additional 456,114 shares during the last quarter. Finally, Man Group plc raised its stake in Clorox by 154.6% during the fourth quarter. Man Group plc now owns 570,503 shares of the company's stock worth $92,655,000 after buying an additional 346,449 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the stock in a transaction dated Wednesday, May 7th. The shares were bought at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.57% of the company's stock.

Clorox Stock Down 3.3%

Clorox stock traded down $4.25 during midday trading on Friday, hitting $123.03. 1,709,082 shares of the stock were exchanged, compared to its average volume of 1,361,693. The Clorox Company has a 52-week low of $122.84 and a 52-week high of $171.37. The stock has a market capitalization of $15.16 billion, a price-to-earnings ratio of 33.61, a price-to-earnings-growth ratio of 2.62 and a beta of 0.54. The business's 50-day moving average price is $134.91 and its 200-day moving average price is $148.35. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business's revenue was down 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.71 EPS. On average, research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Wells Fargo & Company decreased their price target on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Citigroup decreased their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. UBS Group decreased their price target on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Barclays decreased their price target on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research note on Wednesday, May 7th. Finally, Morgan Stanley reduced their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.